* PolyPid Ltd PYPD.OQ reported a quarterly adjusted loss
of
$3.97 per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of
$-9.60. The mean expectation of three analysts for the quarter
was for a loss of $3.58 per share. Wall Street expected
results to range from $-5.16 to $-2.17 per share.
* Reported revenue was zero; analysts expected zero.
* PolyPid Ltd's reported EPS for the quarter was a loss of
$3.97.
* The company reported a quarterly loss of $6.36 million.
* PolyPid Ltd shares had risen by 78.6% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 4.8%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* Wall Street's median 12-month price target for PolyPid Ltd
is
$13.00
This summary was machine generated from LSEG data February 14 at
03:56 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -3.58 -3.97 Missed
Sep. 30 2023 -4.16 -3.40 Beat
Jun. 30 2023 -9.18 -3.90 Beat
Mar. 31 2023 -7.79 -8.40 Missed